Stage I-III Hodgkin's Disease: Outcome and Pattern of Failure Following Treatment with Radiation Therapy and Chemotherapy in a Modern Era

References

• Lee, C.K.K., Aepli, D. and Nierengarten, M.E. (2000) “The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience”, International Journal of Radiation Oncology Biology and Physics 48,169–179.
   PubMed Web of Science ®Google Scholar
• Aisenberg, A.C. (1999) “Problems in Hodgkin's disease management”. Blood 93, 761–779.
   PubMed Web of Science ®Google Scholar
• Golomb, H.M. (1998) “Management of early-stage Hodgkin's disease: a continuing evolution”, Seminars of Oncology 25, 476–482.
   PubMed Web of Science ®Google Scholar
• The International Hodgkin's Disease Collaborative Group-Specht, L., Gray, R.G., Clarke, M.J. and Peto, R. (1998) “Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomised trials involving 3,888 patients”, Journal of Clinical Oncology 16, 830–843.
   PubMed Web of Science ®Google Scholar
• Ng, A.K., Weeks, J.C., Mauch, P.M. and Kuntz, K.M. (1999) “Decision analysis on alternative treatment strategies for favourable-prognosis, early-stage Hodgkin's disease”, Journal of Clinical Oncology 17, 3577–3585.
   PubMed Web of Science ®Google Scholar
• Horning, S.J., Williams, J., Bartlett, N.L., Bennett, J.M., Hope, R.T., Neuberg, D. and Cassileth, P. (2000) “Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group Pilot Study E1492”, Journal of Clinical Oncology 18, 972–980.
   PubMed Web of Science ®Google Scholar
• Jones, E.J. and Mauch, P. (1996) “Limited radiation therapy for selected patients with pathological stages IA and IIA Hodgkin's disease”, Seminars in Radiation Oncology 6, 162–171.
   PubMedGoogle Scholar
• Mauch, P. (1998) “What is the role for adjuvant radiation therapy in advanced Hodgkin's disease?”, Journal of Clinical Oncology 16, 815–817.
   PubMed Web of Science ®Google Scholar
• Wu, J.J. and Prosnitz, L.R. (1996) “The role of adjuvant radiation therapy for stages III and IV Hodgkin's disease”, Seminars in Radiation Oncology 6, 196–209.
   PubMedGoogle Scholar
• Kaplan, E.L. and Meier, P. (1958) “Non parametric estimation from incomplete observations”, Journal American Statistic Association 53, 457–481.
   Web of Science ®Google Scholar
• Cox, D.R. (1972) “Regression models and life tables”, Journal R Statistic Society (B) 34, 187–220.
   Web of Science ®Google Scholar
• Vlachaki, M.T., Ha, C.S., Hagemeister, F.B., Fuller, L.M., Rodríguez, M.A., Hess, M.A., Tucker, S.L., Cabanillas, F. and Cox, J.D. (1998) “Stage I Hodgkin's disease: radiation therapy and chemotherapy at the University of Texas M.D. Anderson Cancer Center, 1967–1997”, Radiology 208, 739–747.
   PubMed Web of Science ®Google Scholar
• Cosset, J.M., Henry-Amar, M., Meerwaldt, J.H., et al, (1992) “The EORTC trials for limited stage Hodgkin's disease”, European Journal of Cancer 28a, 1847–1850.
   PubMed Web of Science ®Google Scholar
• Gospodarowicz, M.K., Sutcliffe, S.B., Clark, R.M., et al, (1992) “Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone”. International Journal of Radiation Oncology Biology and Physics 22, 859–865.
   PubMed Web of Science ®Google Scholar
• Longo, D.L., Glatstein, E., Duffey, P.L., Young, R.C., Ihde, D.C., Bastian, A.W., Wilson, W.H., Wittes, R.E., Jaffe, E.S., Hubbard, S.M. and De Vita, J.R.V.T. (1997) “Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease”, journal of Clinical Oncology 15, 3338–3346.
   PubMed Web of Science ®Google Scholar
• Hughes-Davies, L., Tarbell, N.J., Coleman, C.N., Silver, B., Shulman, L.N., Linggood, R., Canellos, G.P. and Mauch, P.M. (1997) “Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement”, International journal of Radiation Oncology Biology and Physics 39, 361–369.
   PubMed Web of Science ®Google Scholar
• Landman-Parker, J., Pacquement, H., Leblanc, T., Habrand, J.L., Terrier-Lacombe, M.J., Bertrand, Y., Perei, Y., Robert, A., Coze, C., Thuret, I., Donadieu, J., Schaison, G., Leverger, G., Lemerle, J. and Oberlin, O. (2000) “Localised childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy—Results of the French Society of Paediatric Oncology Study MDH90”, journal of Clinical Oncology 18,1500–1507.
   PubMed Web of Science ®Google Scholar
• Shore, T., Nelson, N. and Weinerman, B. (1990) “A metaanalysis of stages I and II Hodgkin's disease”, Cancer 65, 1155–1160.
   PubMed Web of Science ®Google Scholar
• Cimino, G., Biti, G.P., Cartoni, C. and Magrini, S.M. (1992) “Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: evidence of a more difficult rescue for patients relapsed after chemotherapy”, European journal of Cancer 28a, 1853–1855.
   PubMed Web of Science ®Google Scholar
• Longo, D.L., Duffey, P.L., Young, R.C., et al., (1992) “Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability of cure”, journal Clinical Oncology 10, 210–218.
   PubMed Web of Science ®Google Scholar
• Healey, E., Tarbell, N., Kalish, L., Silver, B., Rosenthal, D., Marcus, K., Shulman, L., Coleman, C., Canellos, G., Weinstein, H. and Mauch, P. (1993) “Prognostic factors for patients with Hodgkin's disease in first relapse”, Cancer 71, 2613–2620.
   PubMed Web of Science ®Google Scholar
• Mauch, P., Kalish, L., Marcus, K., Shulman, L., Krill, E., Tarbell, N., Silver, B., Weinstein, G., Come, S., Canellos, G. and Coleman, C. (1995) “Long-term survival in Hodgkin's disease: relative impact of mortality, infection, second tumours and cardiovascular disease”, Cancer journal Science American 1, 33–42.
   PubMedGoogle Scholar
• Hellman, S. and Mauch, P. (1982) “Role of radiation therapy in the treatment of Hodgkin's disease”, Cancer Treatment Report 66, 915–923.
   PubMedGoogle Scholar
• Liao, Z., Ha, C.S., Fuller, L.M., Hagemeister, F.B., Cabanillas, F., Tucker, S.L., Hess, M.A. and Cox, J.D. (1998) “Subdiaphragmatic stage I and II Hodgkin's disease: long-term follow-up and prognostic factors”, International journal of Radiation Oncology Biology and Physics 41,1047–1056.
   PubMed Web of Science ®Google Scholar
• Mauch, P., Canellos, G., Shulman, L., et al., (1995) “Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial”, journal of Clinical Oncology 13, 947–952.
   PubMed Web of Science ®Google Scholar
• Haybittle, J.L., Hayhoe, F.G.J., Easterling, M.J., et al., (1985) “Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognosis index”, Lancet 1, 967–972.
   PubMed Web of Science ®Google Scholar
• Somers, R., Tubiana, M. and Henry-Amar, M. (1989) “EORTC Lymphoma Cooperative Group studies in clinical stage I—II Hodgkin's disease 1963–1987”, Recent Results in Cancer Research 117, 175–181.
   PubMedGoogle Scholar
• Hoppe, R.T., Horning, S.J., Hancok, S.L., et al., (1989) “Current Stanford clinical trials for Hodgkin's disease”, Recent Results in Cancer Research 117,182–190.
   PubMedGoogle Scholar
• Wirth, A., Chao, M., Corry, J., Laidlaw, C., Yuen, K., Ryan, G., Byram, D., Davis, S., Kiffer, J., Quong, G. and Liew, K. (1999) “Mantle irradiation alone for clinical stage I—II Hodgkin's disease: long-term follow-up and analysis of prognostic factors in 261 patients”, journal of Clinical Oncology 17, 230–240.
   PubMed Web of Science ®Google Scholar
• Hancock, S.L. and Hoppe, R.T. (1996) “Long-term complications of treatment and causes of Mortality after Hodgkin's disease”, Seminars Radiation Oncology 6, 225–242.
   PubMedGoogle Scholar
• Cosset, J.M., Henry-amar, M. and Meerwaldt, J.H. (1991) “Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience”, Annals of Oncology 2(Suppl. 2), 77–82.
   PubMedGoogle Scholar
• Henry-amar, M. (1992) “Second cancer after the treatment of Hodgkin's disease: a report from the International Database on Hodgkin's disease”, Annals of Oncology 3(Suppl. 4), 117–128.
   PubMedGoogle Scholar
• Swerdlow, A.J., Douglas, A.J., Vaughan Hudson, G., Vaughan Hudson, B., Bennett, M.H. and MacLennan, K.A. (1992) “Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation”, British Medical journal 304, 1137–1143.
   PubMed Web of Science ®Google Scholar
• Vlachaki, M.T., Ha, C.S., Hagemeister, F.B., Fuller, L.M., Rodríguez, M.A., Besa, P.C., Hess, M.A., Brown, B.B., Cabanillas, F. and Cox, J.D. (1997) “Long-term outcome of treatment for Ann Arbor stage I Hodgkin's disease: patterns of failure, late toxicity and second malignancies”, International journal of Radiation Oncology Biology and Physics 39, 609–616.
   PubMed Web of Science ®Google Scholar
• Tucker, M.A., Coleman, C.N. and Cox, R.S. (1988) “Risk of second cancer after treatment for Hodgkin's disease”, New England journal of Medicine 318, 76–81.
   PubMed Web of Science ®Google Scholar
• Meadows, A.T., Obringer, A.C., Marrero, O., et al., (1989) “Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors”, Medical Pediatrics Oncology 17, 477–484.
   PubMedGoogle Scholar
• Swerdlow, A.J., Barber, J.A., Vaughan Hudson, G., Cunningham, D., Gupta, R.K., Hancock, B.W., Horwich, A., Lister, T.A. and Linch, D.C. (2000) “Risk of second malignancy after Hodgkin's disease in a Collaborative British Cohort: the relation to age at treatment”, Journal of Clinical Oncology 18, 498–509.
   PubMed Web of Science ®Google Scholar
• Henry-amar, M. and Somers, R. (1990) “Survival outcome after Hodgkin's disease: a report from the International Data Base on Hodgkin's Disease”, Seminars of Oncology 17,758–768.
   PubMed Web of Science ®Google Scholar
• Biti, G., Cellai, E., Magrini, S.M., Papi, M.G., Ponticelli, P. and Boddi, V. (1994) “Second solid tumours and leukaemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution”, International journal of Radiation Oncology Biology and Physics 29, 25–31.
   PubMed Web of Science ®Google Scholar
• Tingier, A., Wasserman, T.H., Klein, E.E., Miller, E.A., Roberts, T., Piephoff, J.V. and Kuck, N. (1997) “The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique”, International journal of Radiation Oncology Biology and Physics 37, 865–870.
   PubMed Web of Science ®Google Scholar
• Cellai, E., Magrini, S.M., Masala, G., Alterini, R., Costantini, A.S., Rigacci, L., Olmastroni, L., Papi, M.G., Spediacci, M.A., Innocenti, F., Bellesi, G.P.R. and Biti, G. (2001) “The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital”, International journal of Radiation Oncology Biology and Physics 49, 1327–1337.
   PubMed Web of Science ®Google Scholar